ChromoGenics appointed Anne-Marie Gullman as interim CFO and Head of Investor Relations as of June 12, 2023. Anne-Marie has broad experience from roles as Finance Manager and CFO and holds a degree in economics from Karlstad University as well as a master's degree in economics from Stockholm University.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.8 SEK | +6.58% | +8.97% | -2.86% |
04-02 | ChromoGenics AB Receives First Order for North America | CI |
03-08 | ChromoGenics AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.86% | 4.16M | |
+19.28% | 15.32B | |
+30.36% | 7.94B | |
+14.48% | 2.57B | |
+22.09% | 823M | |
+1.25% | 411M | |
+2.64% | 357M | |
+7.51% | 233M | |
+14.62% | 198M | |
+4.86% | 165M |
- Stock Market
- Equities
- CHRO Stock
- News ChromoGenics AB
- Chromogenics Appoints Anne-Marie Gullman as Interim CFO as of June 12, 2023